Heterocyclic Compounds: News and Research on Pyrimidine Nucleosides

MeSH tree: D03.383.742.680

New treatment eliminates bladder cancer in 82% of patients

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously resisted treatment.

How modified RNA tricks the innate immune system

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component of this system are pattern recognition receptors, which recognize non-self RNA—such as that from ...

page 1 from 8